|
Wednesday, November 16, 2022 |
|
|
Cellular metabolism is the process by which cells generate energy. The process can be dysregulated in many diseases and pathologies, including cancer, neurodegeneration, and diabetes. Current biochemical assays for metabolism are limited to either cell-destructive protocols, such as mRNA analysis, or they measure readouts from collective cell populations, such as oxygen consumption assays. Nondestructive measurements of metabolism with single-cell resolution are needed to study the contributions of metabolic heterogeneity to disease progression, cancer metastasis, and resistance to therapies.
Fluorescence lifetime imaging of the metabolic coenzymes, reduced nicotinamide adenine (phosphate) dinucleotide (NAD(P)H), and oxidized flavin adenine dinucleotide (FAD) provides a label-free method to interrogate cellular metabolism. Both coenzymes, NAD(P)H and FAD, exist in either a free or protein-bound configuration with a distinct fluorescence lifetime. Single-cell segmentation and analysis of fluorescence lifetime images allow metabolic measurements at the cellular level. To facilitate cell-level analysis of fluorescence images, Alex Walsh of Texas A&M University and her colleagues are developing automated segmentation algorithms. Additionally, they are creating and testing models for predicting cell phenotypes from fluorescence lifetime metrics.
Who should attend:
Researchers, clinicians, lab managers, engineers, and those who use fluorescence microscopy in their work. Those who are interested in or who work in imaging cells. Anyone who uses chemical microscopy, spectroscopy, photolysis, imaging, and molecular research in industries such as medicine, biomedicine, pharmaceuticals, test and measurement, and cancer research.
About the presenter:
Alex Walsh (she/her) is an assistant professor in the Department of Biomedical Engineering at Texas A&M University. She leads the Quantitative Optical Imaging Lab, which seeks to develop and optimize optical imaging technologies for studying dynamic biological processes and identifying prognostic biomarkers of disease, progression, and response to treatment. Walsh is a founding member of her department’s Respect, Equity, Diversity and Inclusion Committee and works to increase diversity and inclusion in science and engineering.
|
|
|
|
Date: Wednesday, November 30, 2022
Time: 1:00 PM - 2:00 PM EST
Space is limited. Reserve your Webinar seat now at: https://attendee.gotowebinar.com/register/5669780569090926604?source=eblast
After registering you will receive a confirmation email containing information about joining the Webinar.
|
|
|
SYSTEM REQUIREMENTS
Operating System
Windows® 7 or later, Mac OS® X 10.9 or later, Linux®, Google ChromeTM OS
AndroidTM OS 5 or later, iOS® 10 or later
Web Browser
Google ChromeTM (most recent 2 versions)
Mozilla Firefox® (most recent 2 versions)
Mobile Devices
AndroidTM 5 or later
iPhone® 4S or later
iPad® 2 or later
Windows Phone® 8+, Windows® 8RT+
|
|
|
|
.: More from Photonics Media
|
|
|